Experimental study of solubility of elemental sulphur in methane

International audienceThe chemical engineering department of LaTEP has been working for many years on theproblem of sulphur deposition especially in natural gas network [1, 2]. The solid sulphurappears immediately downstream of a pressure reduction facility. One of the hypothesesproposed to explain the solid formation, based on a thermodynamic approach, is thedesublimation of sulphur. During gas expansion, both pressure and temperature decrease.Consequently the gas may become over saturated in sulphur. Because we are below thetemperature of sulphur triple point, part of the gaseous sulphur can be transformed into solidparticles. Thus, it is important to obtain solubility data of sulphur in natural gases. Methane isthe major natural gas component. So, it is of importance to measure solubility of elementalsulphur in CH4. In this paper experimental measurements up to a pressure and temperature of30 MPA and 363.15 K are presented.The principle of the experimental pilot can be resumed following three steps: saturationof the gas with sulphur, trap of all the dissolved gaseous sulphur and finally quantification.Although the principle is simple, experimental difficulties occur at the three steps. A variablevolume equilibrium cell is used to saturate the gas with sulphur. Since sulphur solubility valueis weak in gas transport conditions, the volume of the cell is necessarily big (0.5 Litre). Thepressure of the equilibrium cell is held constant thanks to a piston during the trapping step. Anoriginal gaseous sulphur trapping method was developed. It is based on the reactiveabsorption of the gaseous sulphur with solvent. Indeed, the gas bubbles into a liquid solutionwhich traps gaseous sulphur. Finally, the solution which contains a standard is analysed bygas chromatography and sulphur is quantified. The total volume of the gas withdrawn isdetermined by a position transducer placed on the autoclave. Then, the sulphur solubilityvalue is calculated

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

BackgroundWe previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15-20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in similar to 80% of cases.MethodsWe report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded.ResultsNo gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5-528.7, P=1.1x10(-4)) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR=3.70[95%CI 1.3-8.2], P=2.1x10(-4)). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR=19.65[95%CI 2.1-2635.4], P=3.4x10(-3)), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR=4.40[9%CI 2.3-8.4], P=7.7x10(-8)). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD]=43.3 [20.3] years) than the other patients (56.0 [17.3] years; P=1.68x10(-5)).ConclusionsRare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

International audienc